Spectral Diagnostics Targets POC Market With Metra Biosystems Purchase
This article was originally published in The Gray Sheet
Executive Summary
Spectral Diagnostics intends to focus its activities on the development and manufacturing of platforms for a variety of point-of-care tests following the acquisition of Metra Biosystems.